Bausch Health
BHC
#4798
Rank
C$2.82 B
Marketcap
C$7.56
Share price
0.37%
Change (1 day)
22.29%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): C-$4.51

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is C-$4.48. In 2025 the company made an earnings per share (EPS) of C$0.58 an increase over its 2024 EPS that were of C-$0.17.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$4.51-876.86%
2025C$0.58-450%
2024C-$0.17-92.59%
2023C-$2.24160.89%
2022C-$0.86-76.64%
2021C-$3.6768.45%
2020C-$2.18-68.91%
2019C-$7.01-57.11%
2018C-$16.35-272.22%
2017C$9.50-199.29%
2016C-$9.56798.7%
2015C-$1.06-128.31%
2014C$3.76-204.62%
2013C-$3.59602.7%
2012C-$0.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
C-$0.33-92.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C-$1.31-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA